153 related articles for article (PubMed ID: 36070895)
1. Decreased Expression of NRF2 Target Genes after Alcohol Exposure in the Background Esophageal Mucosa of Patients with Esophageal Squamous Cell Carcinoma.
Toda S; Hatta W; Asanuma K; Asano N; Ono Y; Abe H; Ogata Y; Saito M; Kanno T; Jin X; Uno K; Koike T; Imatani A; Hamada S; Nakamura T; Nakaya N; Masamune A
Tohoku J Exp Med; 2022 Oct; 258(3):195-206. PubMed ID: 36070895
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice.
Hirohashi K; Ohashi S; Amanuma Y; Nakai Y; Ida T; Baba K; Mitani Y; Mizumoto A; Yamamoto Y; Kikuchi O; Matsubara J; Yamada A; Miyamoto S; Seno H; Matsuda T; Muto M
Carcinogenesis; 2020 Apr; 41(2):194-202. PubMed ID: 31074772
[TBL] [Abstract][Full Text] [Related]
3. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes.
Tajiri A; Ishihara R; Sakurai H; Nakamura T; Tani Y; Inoue T; Matsueda K; Miyake M; Waki K; Fukuda H; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Matsunaga T
J Gastroenterol; 2022 Sep; 57(9):630-639. PubMed ID: 35788888
[TBL] [Abstract][Full Text] [Related]
5. ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment.
Flashner S; Shimonosono M; Tomita Y; Matsuura N; Ohashi S; Muto M; Klein-Szanto AJ; Alan Diehl J; Chen CH; Mochly-Rosen D; Weinberg KI; Nakagawa H
Carcinogenesis; 2024 Feb; 45(1-2):95-106. PubMed ID: 37978873
[TBL] [Abstract][Full Text] [Related]
6. NRF2/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma.
Odera JO; Xiong Z; Huang C; Gu N; Yang W; Githang'a J; Odera E; Paiboonrungruang C; Chen X
Biochem J; 2020 Aug; 477(16):3075-3089. PubMed ID: 32776152
[TBL] [Abstract][Full Text] [Related]
7. Genetic modulation of ADH1B and ALDH2 polymorphisms with regard to alcohol and tobacco consumption for younger aged esophageal squamous cell carcinoma diagnosis.
Lee CH; Wu DC; Wu IC; Goan YG; Lee JM; Chou SH; Chan TF; Huang HL; Hung YH; Huang MC; Lai TC; Wang TN; Lan CC; Tsai S; Lin WY; Wu MT
Int J Cancer; 2009 Sep; 125(5):1134-42. PubMed ID: 19449376
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.
Katada C; Muto M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Sakuramoto S; Yamashita K; Masaki T; Nakayama M; Okamoto M; Koizumi W
Dis Esophagus; 2014 Jul; 27(5):457-62. PubMed ID: 23009284
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the aldehyde breath test for predicting metachronous recurrence in patients with esophageal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma.
Sasaki F; Mawatari S; Oda K; Yano H; Maeda H; Tanaka A; Arima S; Kumagai K; Tanoue S; Hashimoto S; Kanmura S; Ido A
Esophagus; 2023 Oct; 20(4):749-756. PubMed ID: 37552454
[TBL] [Abstract][Full Text] [Related]
10. Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer.
Muto M; Nakane M; Hitomi Y; Yoshida S; Sasaki S; Ohtsu A; Yoshida S; Ebihara S; Esumi H
Carcinogenesis; 2002 Oct; 23(10):1759-65. PubMed ID: 12376487
[TBL] [Abstract][Full Text] [Related]
11. Alcohol Intake Interacts with Functional Genetic Polymorphisms of Aldehyde Dehydrogenase (ALDH2) and Alcohol Dehydrogenase (ADH) to Increase Esophageal Squamous Cell Cancer Risk.
Suo C; Yang Y; Yuan Z; Zhang T; Yang X; Qing T; Gao P; Shi L; Fan M; Cheng H; Lu M; Jin L; Chen X; Ye W
J Thorac Oncol; 2019 Apr; 14(4):712-725. PubMed ID: 30639619
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
Gao Y; Li M; Wang B; Ma Y
Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
[TBL] [Abstract][Full Text] [Related]
13. Deficient aldehyde dehydrogenase 2 is associated with increased risk for esophageal squamous cell carcinoma in the presence of gastric hypochlorhydria.
Oikawa T; Iijima K; Koike T; Uno K; Horii T; Iwai W; Abe Y; Asano N; Imatani A; Shimosegawa T
Scand J Gastroenterol; 2010 Nov; 45(11):1338-44. PubMed ID: 20521872
[TBL] [Abstract][Full Text] [Related]
14. Relationship between esophageal squamous cell carcinoma risk and alcohol-related ALDH2 and ADH1B polymorphisms: Evidence from a meta-analysis and Mendelian randomization analysis.
Zhang B; Peng YH; Luo Y; Hong CQ; Lin YW; Zhang YL; Xu YW; Su XF; Wu FC
Cancer Med; 2023 Oct; 12(20):20437-20449. PubMed ID: 37795758
[TBL] [Abstract][Full Text] [Related]
15. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma.
He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K
Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism.
Katada C; Yokoyama T; Mure K; Doyama H; Nakanishi H; Shimizu Y; Yamamoto K; Furue Y; Tamaoki M; Koike T; Kawahara Y; Kiyokawa H; Konno M; Yokoyama A; Ohashi S; Ishikawa H; Yokoyama A; Muto M
Jpn J Clin Oncol; 2023 Aug; 53(9):774-780. PubMed ID: 37370215
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
[TBL] [Abstract][Full Text] [Related]
18. Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma.
Cai L; You NC; Lu H; Mu LN; Lu QY; Yu SZ; Le AD; Marshall J; Heber D; Zhang ZF
Cancer; 2006 Jun; 106(11):2345-54. PubMed ID: 16639733
[TBL] [Abstract][Full Text] [Related]
19. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment.
Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J
Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437
[TBL] [Abstract][Full Text] [Related]
20. African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks.
Erkizan HV; Johnson K; Ghimbovschi S; Karkera D; Trachiotis G; Adib H; Hoffman EP; Wadleigh RG
BMC Cancer; 2017 Jun; 17(1):426. PubMed ID: 28629367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
